John Sarbanes

So you have sameness issues now that are kind of initiated from the innovator brand side of the equation.

Thank you, Mr. Chairman. Thank you, Dr. Woodcock. You are one of the best witnesses we get up here and I appreciate your testimony.

I will be interested to hear testimony that backs those kinds of assumptions up because I am skeptical of them, as I think you are, and certainly Congressman Waxman has indicated his skepticism about that.

It seems to me this notion that if a trial lawyer has a positive opinion of the proposal, that somehow that should taint, undermine, or eliminate the concerns that the broad public has about seeing this kind of proposal.

Instead of harnessing the power of consumer choice to lower costs overall by aligning lower cost sharing with lower total costs, the plans divide the interests of individual beneficiaries on the one hand, and the Medicare Program on the…

I think it is outrageous that there--you have independent community pharmacists that are essentially being locked out of the opportunity to participate in a preferred pharmacy network.

It is certainly fair for the program to expect that if the plans are securing discounts, that some of that benefit would come back to the program and to the taxpayers.

I think it is a fair expectation on the part of the taxpayers and the beneficiaries that periodically you kick the tires on the program.

I think seniors are being told that by fear-mongering members of the other party who don't like the ACA.

I appreciate you convening this hearing so we can examine this important topic and the proposed legislation to address this issue of the use of performance-enhancing drugs in the horseracing industry.

This is an important topic of discussion. You do these things--to examine these things, you make sure that a sport like this is clean because it is in the long-term interest of the industry in maintaining the vibrancy of the industry in…

Thank you, Mr. Chairman. Dr. Shuren, I know when last year we were debating the various proposals around this reform one of the issues was where to draw the line, what the proper balance should be in terms of regulating medical devices.

I just want to pick up on the end of those comments, and thank you, Dr. Woodcock, for being here...

So this notion that people are being turned away from an affordable product that provides good, quality care is preposterous.

My understanding is that a lot of the companies, insurers that have been offering plans in the individual market, the ones who are sending out these notices are actually repositioning themselves in the health insurance exchange to offer…

The bigger story is that people want to access affordable health care coverage, and they're coming to these sites.

I find the testimony about the job creation around this project compelling. However, I don't accept the notion that there aren't other tremendous opportunities to create jobs.

This tar sands oil is going across the United States to be refined in Texas and then is bound for world markets.

When you have a spill involving this kind of tar sands oil, it is very, very difficult to clean it up.

This is the dirtiest source of transportation fuel that is currently available.

I have deep, deep reservations about the Keystone XL pipeline and have for a long time.

There needs to be a national approach to addressing this issue.

Overwhelming support not only for cleaning up the waters of the rivers and streams of the Chesapeake Bay, but for paying for it.

I like the concept that we have now, in effect, an early warning system, on the political side of this to check in at regular intervals to adjust and enforce and insist in ways that we could not do before with the way the plan was designed…

If you invest in the things that clean up Chesapeake Bay, you are also investing in things that create jobs.